Milestone Scientific (NYSEAMERICAN:MLSS) Announces Quarterly Earnings Results, Hits Estimates

Milestone Scientific (NYSEAMERICAN:MLSSGet Rating) released its earnings results on Tuesday. The medical instruments supplier reported ($0.03) EPS for the quarter, meeting the consensus estimate of ($0.03), Fidelity Earnings reports. Milestone Scientific had a negative net margin of 79.28% and a negative return on equity of 39.43%.

Shares of NYSEAMERICAN:MLSS opened at $0.87 on Thursday. Milestone Scientific has a 12 month low of $0.75 and a 12 month high of $3.00. The stock has a market cap of $59.26 million, a price-to-earnings ratio of -9.67 and a beta of 1.34.

A number of large investors have recently modified their holdings of the business. Morgan Stanley boosted its stake in shares of Milestone Scientific by 1,855.2% in the 2nd quarter. Morgan Stanley now owns 774,494 shares of the medical instruments supplier’s stock valued at $1,898,000 after purchasing an additional 734,883 shares during the last quarter. Sequoia Financial Advisors LLC bought a new position in shares of Milestone Scientific in the 1st quarter valued at about $86,000. State Street Corp boosted its stake in shares of Milestone Scientific by 83.9% in the 4th quarter. State Street Corp now owns 87,700 shares of the medical instruments supplier’s stock valued at $181,000 after purchasing an additional 40,000 shares during the last quarter. Barclays PLC boosted its stake in shares of Milestone Scientific by 475.6% in the 4th quarter. Barclays PLC now owns 40,842 shares of the medical instruments supplier’s stock valued at $84,000 after purchasing an additional 33,747 shares during the last quarter. Finally, Jane Street Group LLC bought a new position in shares of Milestone Scientific in the 1st quarter valued at about $35,000. 8.82% of the stock is currently owned by hedge funds and other institutional investors.

Separately, Maxim Group dropped their price objective on shares of Milestone Scientific from $6.00 to $4.00 in a research note on Monday, April 4th.

Milestone Scientific Company Profile (Get Rating)

Milestone Scientific Inc designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic.

Recommended Stories

Earnings History for Milestone Scientific (NYSEAMERICAN:MLSS)

Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.